“I think it’s essential that people keep signing up to these type of trials to push research forward.”
A trial looking at two different types of endoscope
Please note - this trial is no longer recruiting patients. We hope to add results when they are available.
This trial is for people who are taking part in the Bowel Cancer Screening Programme (BCSP) and may be offered a test called a colonoscopy.
As part of the bowel cancer screening programme you have been offered a test called a colonoscopy. This test uses a camera on the end of a flexible tube (endoscope) to look at the inside of your bowel.
Doctors look for and remove small growths called
In this trial researchers want to compare 2 makes of camera (endoscope) to find out if one is better than the other.
The aim of this trial is to find out if one endoscope is better than the other at helping doctors to
- See the bowel more clearly and identify any suspicious areas
- See polyps
- Remove polyps
- Do the colonoscopy more easily and so cause less discomfort
Who can enter
You may be able to enter this trial if you
- Have been offered a colonoscopy as part of the National Bowel Cancer Screening Programme
- Are having your colonoscopy at, University College Hospital London or Cambridge University Hospitals NHS Foundation Trust
You cannot enter this trial if you are unable to have a colonoscopy.
This trial will recruit 364 people. It is a randomised trial. The people taking part will be put in to one of 2 groups
- Group 1 have a colonoscopy using a Olympus Lucera System endoscope
- Group 2 have a colonoscopy using a Pentax HiLine endoscope
The procedure for having the colonoscopy is the same for both groups.
There are no extra hospital visits.
As you would be having a colonoscopy anyway as part of the national screening programme, no extra side effects are expected as a result of taking part in the trial. We have more information about colonoscopy.
How to join a clinical trial
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Dr Matthew Banks
Experimental Cancer Medicine Centre (ECMC)
University College London (UCL)